CNC.IBILI – Center for Neuroscience and Cell Biology – Institute for Biomedical Imaging and Life Sciences
Established in 2013, CNC.IBILI Consortium at University of Coimbra (UC) integrates the Centre for Neuroscience and Cell Biology (CNC) and the Institute for Biomedical Imaging and Life Sciences (IBILI). CNC.IBILI was recently renamed as CIBB (Centre for Innovative Biomedicine and Biotechnology) and integrates CNC and iCBR (Coimbra Institute for Clinical and Biomedical Research; former IBILI). CNC.IBILI/CIBB is the result of a continuous and ongoing effort to bring together in a single hub of excellence researchers in Biomedicine and Biotechnology. It is a leading top-ranking research institute in Life & Health Sciences, graded Excellent in all FCT evaluations, with strong international recognition in several research areas. CNC.IBILI/CIBB, a UC flagship in biomedical sciences, hosts researchers from the faculties of Medicine, Pharmacy, Sciences and Economics, from Coimbra University Hospitals (CHUC) and Healthcare system and key collaborators from biotech and pharmaceutical industry.
CNC.IBILI/CIBB currently has over 580 members including integrated PhD holders (305) and supporting technicians/officers (ca. 60). Committed to fundamental and translational research and advanced training it has three strategic research lines: Neuroscience & Disease; Metabolism, Ageing & Disease, and Innovative Therapies. One core scientific activity is related with Vision Diseases. Researchers have been committed to clarify the pathogenic mechanisms underlying retinal degenerative diseases, such as diabetic retinopathy, glaucoma or age-related macular degeneration, to identify potential drug targets and to develop new advanced therapies for these diseases. The identification of new biomarkers of disease and disease progression has been also a major goal. CIBB is competitive in obtaining (inter)national research funding and uniquely positioned in translating fundamental research into clinical and/or marketable applications. CIBB’s activities are supported by world-class core facilities/infrastructures, including (a) the microscopy Units; (b) a cutting-edge medical imaging centre (ICNAS) with MRI, PET and a cyclotron for tracer synthesis; (c) state-of-the-art high-throughput screening platform; (d) Mass Spectrometry, Flow Cytometry, and Next-Generation Sequencing Units. (e) Imaging and electrophysiology for vision research; (f) Animal Facilities.